Intravenous ethanol increases dopamine release in the ventral striatum in humans: PET study using bolus-plus-infusion administration of [11 C]raclopride

Journal of Perinatology

Volumn 35, Issue 3, 2015, Pages 424-431

  Aalto, Sargo ^a,b   Ingman, Kimmo ^a   Alakurtti, Kati ^a   Kaasinen, Valtteri ^a   Virkkala, Jussi ^c   Någren, Kjell ^a   Rinne, Juha O ^a   Scheinin, Harry ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

^c PIRKANMAA HOSPITAL DISTRICT   (Finland)

Author keywords

alcohol; bolus plus infusion; dopamine; ethanol; positron emission tomography; 11C raclopride

Indexed keywords

ALCOHOL; DOPAMINE; RACLOPRIDE C 11; DOPAMINE RECEPTOR BLOCKING AGENT; RACLOPRIDE; RADIOISOTOPE;

ALCOHOL BLOOD LEVEL; ARTICLE; AUTOMATION; CAUDATE NUCLEUS; DOPAMINE RELEASE; HUMAN; HUMAN EXPERIMENT; INTERVENTION STUDY; MALE; NEUROIMAGING; NORMAL HUMAN; PET SCANNER; PLEASURE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; VENTRAL STRIATUM; DRUG EFFECTS; IMAGE PROCESSING; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PROCEDURES; SCINTISCANNING; SECRETION (PROCESS); YOUNG ADULT;

DOPAMINE; DOPAMINE ANTAGONISTS; ETHANOL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFUSIONS, INTRAVENOUS; MALE; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; RADIOISOTOPES; VENTRAL STRIATUM; YOUNG ADULT;

EID: 84938496490     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jcbfm.2014.209     Document Type: Article

References (35)

1. Pierce RC, Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev 2006; 30: 215-238.
2. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 2000; 20: 423-451.
3. Salonen I, Hietala J, Laihinen A, Lehikoinen P, Leino L, Någren K et al. A PET study on the acute effect of ethanol on striatal D2 dopamine receptors with [11C] raclopride in healthy males. Hum Psychopharmacol 1997; 12: 145-152.
4. Boileau I, Assaad JM, Pihl RO, Benkelfat C, Leyton M, Diksic M et al. Alcohol promotes dopamine release in the human nucleus accumbens. Synapse 2003; 49: 226-231.
5. Yoder KK, Kareken DA, Seyoum RA, O'Connor S J, Wang C, Zheng QH et al. Dopamine D(2) receptor availability is associated with subjective responses to alcohol. Alcohol Clin Exp Res 2005; 29: 965-970.
6. Yoder KK, Constantinescu CC, Kareken DA, Normandin MD, Cheng TE, O'Connor SJ et al. Heterogeneous effects of alcohol on dopamine release in the striatum: a PET study. Alcohol Clin Exp Res 2007; 31: 965-973.
7. Yoder KK, Morris ED, Constantinescu CC, Cheng TE, Normandin MD, O'Connor SJ et al. When what you see isn't what you get: alcohol cues, alcohol administration, prediction error, and human striatal dopamine. Alcohol Clin Exp Res 2009; 33: 139-149.
8. Urban NB, Kegeles LS, Slifstein M, Xu X, Martinez D, Sakr E et al. Sex differences in striatal dopamine release in young adults after oral alcohol challenge: a positron emission tomography imaging study with [(1)(1)C]raclopride. Biol Psychiatry 2010; 68: 689-696.
9. Sullivan JM, Kim SJ, Cosgrove KP, Morris ED. Limitations of SRTM, Logan graphical method, and equilibrium analysis for measuring transient dopamine release with [(11)C]raclopride PET. Am J Nucl Med Mol Imaging 2013; 3: 247-260.
10. Yoder KK, Wang C, Morris ED. Change in binding potential as a quantitative index of neurotransmitter release is highly sensitive to relative timing and kinetics of the tracer and the endogenous ligand. J Nucl Med 2004; 45: 903-911.
11. Carson RE. PET physiological measurements using constant infusion. Nucl Med Biol 2000; 27: 657-660.
12. Watabe H, Endres CJ, Breier A, Schmall B, Eckelman WC, Carson RE. Measurement of dopamine release with continuous infusion of [11C]raclopride: optimization and signal-to-noise considerations. J Nucl Med 2000; 41: 522-530.
13. Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 2003; 23: 285-300.
14. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33: 27-39.
15. Brasser SM, McCaul ME, Houtsmuller EJ. Alcohol effects during acamprosate treatment: a dose-response study in humans. Alcohol Clin Exp Res 2004; 28: 1074-1083.
16. Bustamante D, Quintanilla ME, Tampier L, Gonzalez-Lira V, Israel Y, Herrera-Marschitz M. Ethanol induces stronger dopamine release in nucleus accumbens (shell) of alcohol-preferring (bibulous) than in alcohol-Avoiding (abstainer) rats. Eur J Pharmacol 2008; 591: 153-158.
17. Gonzales RA, Weiss F. Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J Neurosci 1998; 18: 10663-10671.
18. Peterson JB, Conrod P, Vassileva J, Gianoulakis C, Pihl RO. Differential effects of naltrexone on cardiac, subjective and behavioural reactions to acute ethanol intoxication. J Psychiatry Neurosci 2006; 31: 386-393.
19. Larsen P UJ, Dahlström K, Jensen M. Synthesis of [11C]methyl iodide by iodination of [11C]methane. Appl Radiat Isot 1997; 48: 153-157.
20. Någren K TP, Helin S, Amir A, Halldin C. Production of high specific radioactivity [C-11]FLB 457 from target produced [C-11]methane. Eur J Nucl Med 2003; 30: S217.
21. Langer O, Någren K, Dolle F, Lundkvist C, Sandell J, Swahn C-G et al. Precursor synthesis and radiolabelling of the dopamine D2 receptor ligand [11C] raclopride from [11C]methyl triflate. J Labelled Comp Radiopharm 1999; 42: 1183-1193.
22. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR et al. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 2001; 21: 1034-1057.
23. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 2007; 27: 1533-1539.
24. Endres CJ, Kolachana BS, Saunders RC, Su T, Weinberger D, Breier A et al. Kinetic modeling of [11C]raclopride: combined PET-microdialysis studies. J Cereb Blood Flow Metab 1997; 17: 932-942.
25. Carson RE, Breier A, de Bartolomeis A, Saunders RC, Su TP, Schmall B et al. Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. J Cereb Blood Flow Metab 1997; 17: 437-447.
26. Martinez D, Gil R, Slifstein M, Hwang DR, Huang Y, Perez A et al. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry 2005; 58: 779-786.
27. Endres CJ, Carson RE. Assessment of dynamic neurotransmitter changes with bolus or infusion delivery of neuroreceptor ligands. J Cereb Blood Flow Metab 1998; 18: 1196-1210.
28. Aalto S, Bruck A, Laine M, Nagren K, Rinne JO. Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-Affinity dopamine D2 receptor ligand [11C]FLB 457. J Neurosci 2005; 25: 2471-2477.
29. Aalto S, Scheinin NM, Kemppainen NM, Nagren K, Kailajarvi M, Leinonen M et al. Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data. Eur J Nucl Med Mol Imaging 2009; 36: 1651-1660.
30. Friston KJ HA, Worsley KJ, Poline J-B, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapp 1995; 2: 189-210.
31. Penttila J, Kajander J, Aalto S, Hirvonen J, Nagren K, Ilonen T et al. Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with [11C]raclopride. Int J Neuropsychopharmacol 2004; 7: 431-439.
32. Alakurtti K, Aalto S, Johansson JJ, Nagren K, Tuokkola T, Oikonen V et al. Reproducibility of striatal and thalamic dopamine D2 receptor binding using [11C] raclopride with high-resolution positron emission tomography. J Cereb Blood Flow Metab 2011; 31: 155-165.
33. Logan J, Fowler JS, Dewey SL, Volkow ND, Gatley SJ. A consideration of the dopamine D2 receptor monomer-Dimer equilibrium and the anomalous binding properties of the dopamine D2 receptor ligand, N-methyl spiperone. J Neural Transm 2001; 108: 279-286.
34. Carson RE, Channing MA, Blasberg RG, Dunn BB, Cohen RM, Rice KC et al. Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab 1993; 13: 24-42.
35. Normandin MD, Schiffer WK, Morris ED. A linear model for estimation of neurotransmitter response profiles from dynamic PET data. NeuroImage 2012; 59: 2689-2699.